e.l.f. Beauty (ELF) closed at $123.28 in the latest trading session, marking a +2.79% move from the prior day. The stock outpaced the S&P 500's daily loss of 0.13%. Elsewhere, the Dow saw a downswing of 0.39%, while the tech-heavy Nasdaq appreciated by 0.15%. The cosmetics company's stock has dropped by 5.32% in the past month, falling short of the Consumer Staples sector's loss of 0.31% and the S&P 500's gain of 3.39%.The upcoming earnings release of e.l.f. Beauty will be of great interest to investors. Th ...

DXP Enterprises (DXPE) ended the recent trading session at $111.84, demonstrating a +1.19% change from the preceding day's closing price. This change outpaced the S&P 500's 0.13% loss on the day. Elsewhere, the Dow saw a downswing of 0.39%, while the tech-heavy Nasdaq appreciated by 0.15%. Coming into today, shares of the industrial products supplier had gained 22.76% in the past month. In that same time, the Industrial Products sector gained 5.75%, while the S&P 500 gained 3.39%. Market participants will b ...

In the latest close session, Marathon Petroleum (MPC) was down 2.65% at $170.78. This change lagged the S&P 500's daily loss of 0.13%. Meanwhile, the Dow lost 0.39%, and the Nasdaq, a tech-heavy index, added 0.15%. Prior to today's trading, shares of the refiner had gained 3.22% lagged the Oils-Energy sector's gain of 4.18% and the S&P 500's gain of 3.39%.The investment community will be paying close attention to the earnings performance of Marathon Petroleum in its upcoming release. The company is slated t ...

Novavax (NVAX) ended the recent trading session at $6.85, demonstrating a -2.28% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.13%. At the same time, the Dow lost 0.39%, and the tech-heavy Nasdaq gained 0.15%. Heading into today, shares of the vaccine maker had gained 6.05% over the past month, outpacing the Medical sector's loss of 0.96% and the S&P 500's gain of 3.39%.Analysts and investors alike will be keeping a close eye on the performance of Novavax in i ...

Recursion Pharmaceuticals (RXRX) ended the recent trading session at $5.81, demonstrating a -2.35% change from the preceding day's closing price. This change lagged the S&P 500's daily loss of 0.13%. Meanwhile, the Dow experienced a drop of 0.39%, and the technology-dominated Nasdaq saw an increase of 0.15%. The stock of biotechnology company has risen by 15.98% in the past month, leading the Medical sector's loss of 0.96% and the S&P 500's gain of 3.39%.Analysts and investors alike will be keeping a close ...

Toll Brothers (TOL) closed the most recent trading day at $119.45, moving -2.78% from the previous trading session. The stock fell short of the S&P 500, which registered a loss of 0.13% for the day. At the same time, the Dow lost 0.39%, and the tech-heavy Nasdaq gained 0.15%. Shares of the home builder have appreciated by 4.14% over the course of the past month, underperforming the Construction sector's gain of 6.66%, and outperforming the S&P 500's gain of 3.39%.The investment community will be closely mon ...

公司业绩表现 - 季度运营资金(FFO)为每股0.51美元 与市场预期一致 但低于去年同期的0.53美元 [1] - 上季度FFO超出预期3.92% 实际为0.53美元 预期为0.51美元 [1] - 过去四个季度中 仅有一次FFO超过市场预期 [1] - 季度营收达2.134亿美元 超出预期0.12% 去年同期为2.1243亿美元 [2] - 过去四个季度中 有三次营收超过市场预期 [2] 市场表现与预期 - 年初至今股价下跌8.6% 同期标普500指数上涨8.3% [3] - 当前Zacks评级为4级(卖出) 预计短期内表现将弱于市场 [6] - 下季度FFO预期为0.50美元 营收预期2.1198亿美元 本财年FFO预期2.07美元 营收预期8.6459亿美元 [7] 行业比较 - 所属REIT零售信托行业在Zacks行业排名中位列前37% [8] - 行业龙头Tanger预计季度每股收益0.56美元 同比增长5.7% 营收预期1.3188亿美元 同比增长7.8% [9][10]

公司业绩表现 - 季度运营资金(FFO)为每股0.48美元 与Zacks共识预期一致 去年同期为0.47美元 [1] - 上一季度FFO超出预期2.13% 实际为0.48美元 预期为0.47美元 [1] - 过去四个季度中 公司两次超出FFO预期 [2] - 季度收入达6.814亿美元 超出共识预期0.67% 去年同期为6.5345亿美元 [2] - 过去四个季度中 公司三次超出收入预期 [2] 市场表现与展望 - 年初至今股价仅上涨0.1% 同期标普500指数上涨8.3% [3] - 当前Zacks评级为3(持有) 预计近期表现与市场持平 [6] - 下季度共识FFO预期为0.48美元 收入预期6.8276亿美元 [7] - 本财年共识FFO预期为1.93美元 收入预期27.2亿美元 [7] 行业情况 - 所属REIT及住宅股权信托行业在Zacks行业排名中位列前35% [8] - Zacks排名前50%行业表现优于后50% 幅度超过2:1 [8] - 同业公司Camden预计季度每股收益1.69美元 同比下降1.2% [9] - Camden收入预期3.9382亿美元 同比增长1.7% [10]

Public Storage (PSA) came out with quarterly funds from operations (FFO) of $4.28 per share, beating the Zacks Consensus Estimate of $4.23 per share. This compares to FFO of $4.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of +1.18%. A quarter ago, it was expected that this self-storage facility real estate investment trust would post FFO of $4.06 per share when it actually produced FFO of $4.12, delivering a surprise of +1.48%.O ...

Cognizant (CTSH) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +3.97%. A quarter ago, it was expected that this information technology consulting and outsourcing firm would post earnings of $1.19 per share when it actually produced earnings of $1.23, delivering a surprise of +3.36%. ...